Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Semax vs Selank: Stimulating Versus Calming Profiles

Semax and Selank represent complementary but distinct peptide approaches to neuropeptide research, each suited to different experimental and clinical questions. Semax Profile: Stimulating, cognitively enhancing, neuroprotective. Produces increased alertness, a

This comparison does not assign a generated winner or score.

  • Semax and Selank represent complementary but distinct peptide approaches to neuropeptide research, each suited to different experimental and clinical questions.
  • Semax Profile: Stimulating, cognitively enhancing, neuroprotective. Produces increased alertness, arousal, motor activity, dopaminergic tone, and attention. Anxiolytic effects are absent; slight anxiety-promoting effects may occur at high doses. Superior neuroprotection in injury models. Preferred for cognitive enhancement, stroke research applications, and attention research.
  • Selank Profile: Calming, anxiolytic, mildly cognitively enhancing. Produces anxiety reduction without sedation, GABAergic modulation without benzodiazepine-like effects, and dual anxiolytic-nootropic profile. No stimulation or arousal. Preferred for anxiety disorder models and conditions where anxiolysis is desired.
  • Practical Research Distinctions: For stroke or traumatic brain injury models, Semax offers superior neuroprotection. For anxiety disorder models, Selank is the preferred choice. For cognitive enhancement without anxiety confounds, Semax suits most paradigms. For combined anxiety-cognition models where anxiety reduction is therapeutic goal, Selank is preferable. Researchers may employ both compounds in sequence (e.g., acute Semax for neuroprotection followed by Selank for anxiety management during research applications) to leverage complementary profiles.